Wrap Text
Dealing in Securities by Associates of Directors
Shoprite Holdings Limited
(Incorporated in the Republic of South Africa)
Registration Number: 1936/007721/06
ISIN: ZAE000012084
JSE share code: SHP
A2X share code: SHP
NSX share code: SRH
LUSE share code: SHOPRITE
(“Shoprite Holdings”)
DEALING IN SECURITIES BY ASSOCIATES OF DIRECTORS
In terms of paragraphs 6.77 to 6.90 of the Listings Requirements of the JSE Limited, shareholders are advised
of the following dealings in Shoprite Holdings ordinary shares by Titan Fincap Solutions (Pty) Ltd (“Titan
Fincap”) and Thibault Square Financial Services (RF) (Pty) Ltd (“Thibault”), as associates of Dr CH Wiese and
Adv. JD Wiese.
Shareholders are referred to the SENS announcements dated 3 and 6 October 2025 in which they were
advised that inter alia Titan Fincap had entered into a scrip borrowing arrangement (the “Third Scrip Loan”) in
respect of 3,831,164 ordinary shares in Shoprite Holdings, and the SENS announcement dated 11 June 2026
for details of the “Fourth Scrip Loan” (collectively the “Prior Announcements”).
Titan Fincap has subsequently acquired Shoprite Holdings ordinary shares to settle the Third Scrip Loan,
details of which are set out below.
PURCHASE OF SHARES AND SETTLEMENT OF THIRD SCRIP LOAN
Names of directors: Dr CH Wiese and Adv. JD Wiese
Designations: Non-executive Director and Alternate Director
Associate: Titan Fincap
Date of transaction: 14 September 2026
Class of securities: Ordinary shares
Nature of transaction: On market purchase of Shoprite Holdings ordinary
shares and settlement of Third Scrip Loan by Titan
Fincap
Number of securities: 3,831,164
Price per security: R313.70
Total value: R1,201,836,146.80
Nature of interest for directors: Indirect beneficial through Titan Fincap which is
controlled by Titan Premier Investments (Pty) Ltd (“TPI”),
of which Dr CH Wiese and Adv. JD Wiese are directors
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
In addition, Titan Fincap sold a total return swap, with a reference price of R313.70 per Shoprite Holdings
ordinary share, which will be settled in cash.
TOTAL RETURN SWAP
Names of directors: Dr CH Wiese and Adv. JD Wiese
Designations: Non-executive Director and Alternate Director
Associate: Titan Fincap
Date of transaction: 14 September 2026
Class of securities: Ordinary shares
Nature of transaction: 1-day total return swap (off market)
Number of securities: 3,831,164
Initial price per security: R313.70 (based on the acquisition price of Shoprite
Holdings ordinary shares referenced above)
Total value: R1,201,836,146.80
Nature of interest for directors: Indirect beneficial through Titan Fincap which is
controlled by TPI, of which Dr CH Wiese and Adv. JD
Wiese are directors
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
Subsequent to the above transactions Titan Fincap entered into the following transactions.
SALE OF SHARES
Names of directors: Dr CH Wiese and Adv. JD Wiese
Designations: Non-executive Director and Alternate Director
Associate: Titan Fincap
Date of transaction: 15 September 2026
Class of securities: Ordinary shares
Nature of transaction: On market sale of Shoprite Holdings ordinary shares by
Titan Fincap
Number of securities: 3,831,164
Price per security: R313.95
Total value: R1,202,793,937.80
Nature of interest for directors: Indirect beneficial through Titan Fincap which is
controlled by TPI, of which Dr CH Wiese and Adv. JD
Wiese are directors
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
Titan Fincap has entered into the “Fifth Scrip Loan”, the details of which are set out below.
Names of directors: Dr CH Wiese and Adv. JD Wiese
Designations: Non-executive Director and Alternate Director
Associate: Titan Fincap
Date of transaction: 16 September 2026
Class of securities: Ordinary shares
Nature of transaction: Scrip borrow of Shoprite Holdings ordinary shares by
Titan Fincap (on market)
Number of securities: 3,831,164
Price per security: R313.95 (based on the sale price of Shoprite Holdings
ordinary shares referenced above)
Total value: R 1,202,793,937.80
Nature of interest for directors: Indirect beneficial through Titan Fincap which is
controlled by TPI, of which Dr CH Wiese and Adv. JD
Wiese are directors
Nature of interest for associate: Direct beneficial
Clearance to deal obtained: Yes
All broker instructions for the above transactions were issued prior to market open on the 14 September 2026,
to be executed on the relevant transaction date, at the preceding day’s closing price.
Shareholders are further advised that the intra-group options between associates of Dr CH Wiese, TPI,
Thibault and Titan Fincap, as described in the Prior Announcements, remain in place. The Pledge and Cession
of Shares referred to in the Prior Announcements has been re-entered into to incorporate the Fifth Scrip Loan.
The above transactions, prior to the exercise of the intra-group options (as outlined in the Prior
Announcements), do not affect any of the voting rights in respect of Shoprite Holdings ordinary shares and the
Shoprite Holdings deferred shares held by Thibault.
Cape Town
17 September 2026
Sponsor
Nedbank Corporate and Investment Banking, a division of Nedbank Limited
Date: 17/09/2026 04:40:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
